[1]
Biswajit Dash et al. 2023. Pharmacological Evaluation of Novel Quinazoline Derivatives for Their Anti-Convulsant and CNS Depressant Activities. Current Overview on Pharmaceutical Science Vol. 7. (Feb. 2023), 12–36. DOI:https://doi.org/10.9734/bpi/cops/v7/18044D.